Brigette Roberts

Brigette Roberts

Director Ejecutivo en IRULYA THERAPEUTICS INC. .

Fortuna: - $ al 30/09/2026

50 años
Finance
Health Technology
Consumer Services

Perfil

Dr. Brigette M.
Roberts, MD, is a Chief Executive Officer & Director at IRulya Therapeutics, Inc. and a Chief Executive Officer & Director at OrphAI Therapeutics, Inc. She is on the Board of Directors at IRulya Therapeutics, Inc. and OrphAI Therapeutics, Inc. Dr. Roberts was previously employed as a Principal by Nomura Securities International, Inc., a Founder by YYC Capital Management LLC, a Principal by Third Point Management Co. LLC, a Principal by Sturzas Institutional Research, Inc., and an Associate by Thomas Weisel Partners LLC.
She also served on the board at Ligand Pharmaceuticals, Inc. She received her undergraduate degree from Harvard University and a doctorate degree from New York University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/05/2026 0 ( -.--% ) - $ 30/09/2026

Cargos activos de Brigette Roberts

EmpresasCargoInicio
IRULYA THERAPEUTICS INC. Director Ejecutivo 08/10/2026
Director Ejecutivo 01/02/2021

Antiguos cargos conocidos de Brigette Roberts.

EmpresasCargoFin
Corporate Officer/Principal 01/12/2012
Fundador 01/01/2012
Gestor de Cartera-Acciones -
LIGAND PHARMACEUTICALS INCORPORATED Director/Miembro de la Junta 01/03/2007
Corporate Officer/Principal 01/01/2003
Ver el detalle de la experiencia de Brigette Roberts.

Formación de Brigette Roberts.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

96

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Finance

Consumer Services

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Brigette Roberts